Cargando…

Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia

Objective: To examine the economic burden and health care utilizations of schizophrenia in the U.S. veteran population. Methods: A retrospective database analysis was performed using the Veterans Health Administration (VHA) Medical SAS® datasets from October 1, 2008 through September 30, 2012. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lin, Kariburyo, M. Furaha, Du, Juan, Wang, Yuexi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471393/
https://www.ncbi.nlm.nih.gov/pubmed/37662026
_version_ 1785099841287749632
author Xie, Lin
Kariburyo, M. Furaha
Du, Juan
Wang, Yuexi
author_facet Xie, Lin
Kariburyo, M. Furaha
Du, Juan
Wang, Yuexi
author_sort Xie, Lin
collection PubMed
description Objective: To examine the economic burden and health care utilizations of schizophrenia in the U.S. veteran population. Methods: A retrospective database analysis was performed using the Veterans Health Administration (VHA) Medical SAS® datasets from October 1, 2008 through September 30, 2012. Patients diagnosed with schizophrenia were identified, and the initial diagnosis date was designated as the index date. A group of patients without schizophrenia of the same age, region, gender and index year were identified and matched by baseline Charlson Comorbidity Index (CCI) score, as the comparison group. Patients in both groups were required to be at least age 18 years and have continuous medical and pharmacy benefits 1 year pre- and 1 year post-index date. One-to-one propensity score matching was used to compare health care costs and utilizations during the follow-up period between the schizophrenia and comparison group patients, adjusted for baseline demographic and clinical characteristics. Results: A total of 171,086 eligible patients were identified for the schizophrenia and control cohorts. After 1:1 matching, a total of 70,045 patients were matched from each cohort with well-balanced baseline characteristics. Patients diagnosed with schizophrenia had significantly higher health care utilization in inpatient (18.12% vs. 2.30%, p<0.01), emergency room (19.67% vs. 6.46%, p<0.01), office (98.32% vs. 53.26%, p<0.01), and outpatient visits (98.53% vs. 54.16%, p<0.01). Higher health care utilizations translated into higher costs for schizophrenic patients including inpatient ($7,228 vs. $613, p<0.01), pharmacy ($1,012 vs. $343, p<0.01), outpatient ($3,998 vs. $1,302, p<0.01), and total costs ($12,238 vs. $2,260, p<0.01) relative to patients in the comparison group. Conclusion: Patients diagnosed with schizophrenia in the U.S. VHA system were associated with a substantial economic burden, compared to their matched controls.
format Online
Article
Text
id pubmed-10471393
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Columbia Data Analytics, LLC
record_format MEDLINE/PubMed
spelling pubmed-104713932023-09-01 Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia Xie, Lin Kariburyo, M. Furaha Du, Juan Wang, Yuexi J Health Econ Outcomes Res Neurological Diseases Objective: To examine the economic burden and health care utilizations of schizophrenia in the U.S. veteran population. Methods: A retrospective database analysis was performed using the Veterans Health Administration (VHA) Medical SAS® datasets from October 1, 2008 through September 30, 2012. Patients diagnosed with schizophrenia were identified, and the initial diagnosis date was designated as the index date. A group of patients without schizophrenia of the same age, region, gender and index year were identified and matched by baseline Charlson Comorbidity Index (CCI) score, as the comparison group. Patients in both groups were required to be at least age 18 years and have continuous medical and pharmacy benefits 1 year pre- and 1 year post-index date. One-to-one propensity score matching was used to compare health care costs and utilizations during the follow-up period between the schizophrenia and comparison group patients, adjusted for baseline demographic and clinical characteristics. Results: A total of 171,086 eligible patients were identified for the schizophrenia and control cohorts. After 1:1 matching, a total of 70,045 patients were matched from each cohort with well-balanced baseline characteristics. Patients diagnosed with schizophrenia had significantly higher health care utilization in inpatient (18.12% vs. 2.30%, p<0.01), emergency room (19.67% vs. 6.46%, p<0.01), office (98.32% vs. 53.26%, p<0.01), and outpatient visits (98.53% vs. 54.16%, p<0.01). Higher health care utilizations translated into higher costs for schizophrenic patients including inpatient ($7,228 vs. $613, p<0.01), pharmacy ($1,012 vs. $343, p<0.01), outpatient ($3,998 vs. $1,302, p<0.01), and total costs ($12,238 vs. $2,260, p<0.01) relative to patients in the comparison group. Conclusion: Patients diagnosed with schizophrenia in the U.S. VHA system were associated with a substantial economic burden, compared to their matched controls. Columbia Data Analytics, LLC 2013-10-08 /pmc/articles/PMC10471393/ /pubmed/37662026 Text en https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (4.0) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurological Diseases
Xie, Lin
Kariburyo, M. Furaha
Du, Juan
Wang, Yuexi
Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
title Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
title_full Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
title_fullStr Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
title_full_unstemmed Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
title_short Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
title_sort assessing the economic burden and health care utilizations of u.s. veteran patients with schizophrenia
topic Neurological Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471393/
https://www.ncbi.nlm.nih.gov/pubmed/37662026
work_keys_str_mv AT xielin assessingtheeconomicburdenandhealthcareutilizationsofusveteranpatientswithschizophrenia
AT kariburyomfuraha assessingtheeconomicburdenandhealthcareutilizationsofusveteranpatientswithschizophrenia
AT dujuan assessingtheeconomicburdenandhealthcareutilizationsofusveteranpatientswithschizophrenia
AT wangyuexi assessingtheeconomicburdenandhealthcareutilizationsofusveteranpatientswithschizophrenia